Getty ImagesNEW DELHI: Shares of . traded 0.16 per cent down in Friday's trade at 11:37AM (IST). Around 53,621 shares changed hands on the counter.
The counter opened at Rs 545.6 and touched an intraday high and low of Rs 550.95 and Rs 537.8, respectively, in the session so far. Shares of the company of Aurobindo Pharma Ltd. quoted a 52-week high of Rs 767.45 and a 52-week low of Rs 503.4.
Total market cap of the Aurobindo Pharma Ltd. stood at Rs 31549.86 crore at the time of writing this report.
Key Financials
The company reported consolidated net sales of Rs 6276.54 crore for the quarter ended 30-Jun-2022, up 7.14 per cent from previous quarter's Rs 5858.25 crore and up 8.53 per cent from the year-ago quarter's Rs 5783.29 crore.
The net profit for latest quarter stood at Rs 520.54 crore, down 32.39 per cent from the same quarter a year ago.
Shareholding pattern
As of 30-Jun-2022, DIIs held 9.82 per cent stake in the firm, while foreign institutional investors held 22.43 per cent and the promoters 51.83 per cent.
Valuation ratio
According to BSE data, the stock traded at a price-to-earnings multiple of 13.15 and a price-to-book ratio of 1.59. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Aurobindo Pharma Ltd. belongs to the Pharma - Indian industry.
The counter opened at Rs 545.6 and touched an intraday high and low of Rs 550.95 and Rs 537.8, respectively, in the session so far. Shares of the company of Aurobindo Pharma Ltd. quoted a 52-week high of Rs 767.45 and a 52-week low of Rs 503.4.
Total market cap of the Aurobindo Pharma Ltd. stood at Rs 31549.86 crore at the time of writing this report.
Key Financials
The company reported consolidated net sales of Rs 6276.54 crore for the quarter ended 30-Jun-2022, up 7.14 per cent from previous quarter's Rs 5858.25 crore and up 8.53 per cent from the year-ago quarter's Rs 5783.29 crore.
The net profit for latest quarter stood at Rs 520.54 crore, down 32.39 per cent from the same quarter a year ago.
Shareholding pattern
As of 30-Jun-2022, DIIs held 9.82 per cent stake in the firm, while foreign institutional investors held 22.43 per cent and the promoters 51.83 per cent.
Valuation ratio
According to BSE data, the stock traded at a price-to-earnings multiple of 13.15 and a price-to-book ratio of 1.59. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Aurobindo Pharma Ltd. belongs to the Pharma - Indian industry.
Experience Your Economic Times Newspaper, The Digital Way!
Read More News on
(What's moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)
...moreDownload The Economic Times News App to get Daily Market Updates & Live Business News.
Pick the best stocks for yourself
Powered by